CME Group Inc. CI A (CME): Price and Financial Metrics
CME Price/Volume Stats
Current price | $215.29 | 52-week high | $223.80 |
Prev. close | $215.60 | 52-week low | $175.73 |
Day low | $212.98 | Volume | 1,755,300 |
Day high | $216.49 | Avg. volume | 1,788,118 |
50-day MA | $212.21 | Dividend yield | 2.14% |
200-day MA | $205.71 | Market Cap | 77.50B |
CME Stock Price Chart Interactive Chart >
CME POWR Grades
- Momentum is the dimension where CME ranks best; there it ranks ahead of 74.09% of US stocks.
- CME's strongest trending metric is Stability; it's been moving down over the last 26 weeks.
- CME ranks lowest in Value; there it ranks in the 3rd percentile.
CME Stock Summary
- With a market capitalization of $72,505,812,486, CME GROUP INC has a greater market value than 96.57% of US stocks.
- The ratio of debt to operating expenses for CME GROUP INC is higher than it is for about 98.04% of US stocks.
- CME's price/sales ratio is 13.56; that's higher than the P/S ratio of 91.95% of US stocks.
- If you're looking for stocks that are quantitatively similar to CME GROUP INC, a group of peers worth examining would be CM, RC, BKCC, CP, and VEL.
- Visit CME's SEC page to see the company's official filings. To visit the company's web site, go to www.cmegroup.com.
CME Valuation Summary
- In comparison to the median Financial Services stock, CME's price/sales ratio is 1100% higher, now standing at 14.4.
- CME's price/sales ratio has moved up 9.8 over the prior 243 months.
Below are key valuation metrics over time for CME.
Stock | Date | P/S | P/B | P/E | EV/EBIT |
---|---|---|---|---|---|
CME | 2023-12-22 | 14.4 | 2.7 | 25.6 | 40.3 |
CME | 2023-12-21 | 14.4 | 2.7 | 25.6 | 40.3 |
CME | 2023-12-20 | 14.2 | 2.7 | 25.2 | 40.0 |
CME | 2023-12-19 | 14.3 | 2.7 | 25.5 | 40.2 |
CME | 2023-12-18 | 14.2 | 2.7 | 25.2 | 40.0 |
CME | 2023-12-15 | 13.9 | 2.6 | 24.7 | 39.7 |
CME Growth Metrics
- The year over year revenue growth rate now stands at 3.64%.
- The 4 year cash and equivalents growth rate now stands at -33.86%.
- The 4 year net income to common stockholders growth rate now stands at 52.34%.
The table below shows CME's growth in key financial areas (numbers in millions of US dollars).
Date | Revenue | Operating Cash Flow | Net Income to Common Stock |
---|---|---|---|
2022-09-30 | 4,958.9 | 2,742.8 | 2,633.1 |
2022-06-30 | 4,841 | 2,716.6 | 2,888.5 |
2022-03-31 | 4,783 | 2,598.8 | 2,744.7 |
2021-12-31 | 4,689.7 | 2,402.4 | 2,617.1 |
2021-09-30 | 4,640.9 | 2,394.4 | 2,435.2 |
2021-06-30 | 4,611.7 | 2,074.2 | 1,920.4 |
CME's Quality Factors
The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.- CME has a Quality Grade of C, ranking ahead of 51.61% of graded US stocks.
- CME's asset turnover comes in at 0.029 -- ranking 320th of 444 Trading stocks.
- CGBD, WELL, and FCRD are the stocks whose asset turnover ratios are most correlated with CME.
The table below shows CME's key quality metrics over time.
Period | Asset Turnover | Gross Margin | ROIC |
---|---|---|---|
2021-09-30 | 0.029 | 1 | 0.025 |
2021-06-30 | 0.031 | 1 | 0.023 |
2021-03-31 | 0.035 | 1 | 0.026 |
2020-12-31 | 0.039 | 1 | 0.030 |
2020-09-30 | 0.043 | 1 | 0.036 |
2020-06-30 | 0.050 | 1 | 0.045 |
CME Price Target
For more insight on analysts targets of CME, see our CME price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.
Average Price Target | $221.47 | Average Broker Recommendation | 1.75 (Moderate Buy) |
CME Group Inc. CI A (CME) Company Bio
CME Group Inc. (Chicago Mercantile Exchange, Chicago Board of Trade, New York Mercantile Exchange, The Commodity Exchange) is an American global markets company. It is the world's largest financial derivatives exchange, and trades in asset classes that include agricultural products, currencies, energy, interest rates, metals, stock indexes and cryptocurrencies futures. The company offers futures contracts and options on futures using its CME Globex trading platforms, fixed income trading via BrokerTec and foreign exchange trading on the EBS platform. In addition, it operates a central counterparty clearing provider, CME Clearing. With a range of pre- and post-trade products and services underpinning the entire lifecycle of a trade, CME Group also offers optimization and reconciliation services through TriOptima, and trade processing services through Traiana. (Source:Wikipedia)
Latest CME News From Around the Web
Below are the latest news stories about CME GROUP INC that investors may wish to consider to help them evaluate CME as an investment opportunity.
Bullish About 2024? CME's Charts Suggest Something ElseI miss those days - but now it provides electronic trading globally on its CME Globex platform. The trading volume has been more active the past three months and the On-Balance-Volume (OBV) line started to move sideways in September and declined in December. A weak OBV line suggests that traders are being more aggressive sellers than buyers. |
CME Group Inc's Dividend AnalysisCME Group Inc (NASDAQ:CME) recently announced a dividend of $5.25 per share, payable on 2024-01-18, with the ex-dividend date set for 2023-12-27. Using the data from GuruFocus, let's look into CME Group Inc's dividend performance and assess its sustainability. What Does CME Group Inc Do? |
Here's Why We're Wary Of Buying CME Group's (NASDAQ:CME) For Its Upcoming DividendCME Group Inc. ( NASDAQ:CME ) is about to trade ex-dividend in the next four days. The ex-dividend date occurs one day... |
CME Group (CME) Benefitted from Unique DiversificationMawer Investment Management, an asset management company, released its third quarter 2023 investor letter. A copy of the same can be downloaded here. In the third quarter, Mawer Investment Management’s International Equity Fund, U.S. Equity Fund, U.S. Mid Cap Equity Fund, Global Equity Fund, Global Small Cap Fund, Emerging Markets Equity Fund, EAFE Large Cap Fund, […] |
CME Group Inc. Announces Fourth-Quarter and Year-End 2023 Earnings Release, Conference CallCME Group Inc. will announce earnings for the fourth quarter and full year of 2023 before the markets open on Wednesday, February 14, 2024. Written highlights for the quarter will be posted on the company's website at 6:00 a.m. Central Time, the same time it provides its earnings press release. The company will also hold an investor conference call that day at 7:30 a.m. Central Time, at which time company executives will take analysts' questions. |
CME Price Returns
1-mo | -2.00% |
3-mo | 2.76% |
6-mo | 11.37% |
1-year | 19.39% |
3-year | 19.18% |
5-year | 57.49% |
YTD | 2.76% |
2023 | 31.32% |
2022 | -22.89% |
2021 | 29.47% |
2020 | -6.34% |
2019 | 9.67% |
CME Dividends
Ex-Dividend Date | Type | Payout Amount | Change | ||||||
---|---|---|---|---|---|---|---|---|---|
Loading, please wait... |
Continue Researching CME
Want to do more research on Cme Group Inc's stock and its price? Try the links below:Cme Group Inc (CME) Stock Price | Nasdaq
Cme Group Inc (CME) Stock Quote, History and News - Yahoo Finance
Cme Group Inc (CME) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...